Impact of pulmonary hypertension on exercise performance in patients with interstitial lung disease undergoing evaluation for lung transplantation

Respirology

Volumn 19, Issue 5, 2014, Pages 675-682

  Armstrong, Hilary F ^a   Schulze, P Christian ^a   Bacchetta, Matthew ^b   Thirapatarapong, Wilawan ^a,c   Bartels, Matthew N ^a  

^a Department of Medicine   (United States)

^b Department of Orthopaedic Surgery   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

cardiopulmonary exercise test; interstitial lung disease; lung transplantation; pulmonary hypertension; respiratory insufficiency

Indexed keywords

CARBON MONOXIDE; CARBON DIOXIDE;

6 MIN WALK TEST; ADULT; CARDIOPULMONARY EXERCISE TEST; CLINICAL EVALUATION; DISEASE SEVERITY; END TIDAL CARBON DIOXIDE TENSION; FEMALE; FUNCTION TEST; HEART CATHETERIZATION; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ARTERY PRESSURE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; LUNG TRANSPLANTATION; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; OXYGEN SATURATION; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; TIDAL VOLUME; AGED; BLOOD PRESSURE; COMPARATIVE STUDY; COMPLICATION; EXERCISE TEST; EXERCISE TOLERANCE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT SELECTION; PHYSIOLOGY; RETROSPECTIVE STUDY; WALKING;

AGED; BLOOD PRESSURE; CARBON DIOXIDE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES, INTERSTITIAL; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; WALKING;

EID: 84902963550     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12306     Document Type: Review

References (32)

1. Hoeper MM, Barber JA, Channick RN, Hassoun PM, Lang IM, Manes A, Martinez FJ, Naeije R, Olschewski H, Pepke-Zaba J, et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J. Am. Coll. Cardiol. 2009; 54 (1 Suppl.): S85-96.
2. Behr J, Ryu JH,. Pulmonary hypertension in interstitial lung disease. Eur. Respir. J. 2008; 31: 1357-1367.
3. Glaser S, Noga O, Koch B, Opitz CF, Schmidt B, Temmesfeld B, Door M, Ewert R, Schaper C,. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir. Med. 2009; 103: 317-324.
4. King TJ, Tooze J, Schwarz M, Brown K, Cherniack R,. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am. J. Respir. Crit. Care Med. 2001; 164: 1171-1181. (Pubitemid 33052246)
5. Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, Ryu JH,. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005; 128: 2393-2399. (Pubitemid 41507585)
6. Shorr A, Wainright J, Cors C, Lettieri C, NAthan S,. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur. Respir. J. 2007; 30: 715-721. (Pubitemid 351194832)
7. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF,. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129: 746-752.
8. Shorr AF, Helman DL, Davies DB, Nathan SD,. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur. Respir. J. 2005; 25: 783-788. (Pubitemid 40667674)
9. Handa T, Nagai S, Miki S, Fushimi Y, Ohta K, Mishima M, Izumi T,. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 2006; 129: 1246-1252.
10. Andersen CU, Mellemkjær S, Hilberg O, Nielsen-Kudsk JE, Simonsen U, Bendstrup E,. Pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test. Respir. Med. 2012; 106: 875-882.
11. American Thoracic Society, American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 2003; 167: 211-277.
12. Paolillo S, Farina S, Bussotti M, Iorio A, Filardi PP, Piepoli MF, Agostoni P,. Exercise testing in the clinical management of patients affected by pulmonary arterial hypertension. Eur. J. Cardiovasc. Prev. Rehabil. 2011; 19: 960-971.
13. Arena R, Guazzi M, Myers J, Grinnen D, Forman DE, Lavie CJ,. Cardiopulmonary exercise testing in the assessment of pulmonary hypertension. Expert. Rev. Respir. Med. 2011; 5: 281-293.
14. Swigris JJ, Olson AL, Shlobin OA, Ahmad S, Brown KK, Nathan SD,. Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respirology 2011; 16: 439-445.
15. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am. J. Respir. Crit. Care Med. 2002; 165: 277-304.
16. Group NETT. A randomized trial comparing lung volume reduction surgery with medical therapy for severe emphysema. N. Engl. J. Med. 2003; 348: 2059-2073.
17. Jones N, Makrides L, Hitchcock C, Chypchar T, McCartney N,. Normal standards for an incremental progressive cycle ergometer test. Am. Rev. Respir. Dis. 1985; 131: 700-708. (Pubitemid 15066853)
18. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, Grinten CPMVD, et al. Standardisation of the measurement of lung volumes. Eur. Respir. J. 2005; 26: 511-522. (Pubitemid 41264217)
19. Crapo R, Morris A, Clayton P, Nixon C,. Lung volumes in healthy nonsmoking adults. Bull. Eur. Physiopathol. Respir. 1982; 18: 419-425. (Pubitemid 12117075)
20. Crapo R, Morris A, Gardner R,. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am. Rev. Respir. Dis. 1981; 123: 659-664. (Pubitemid 11117589)
21. Crapo R, Morris A,. Standardized single-breath normal values for carbon monoxide diffusing capacity. Am. Rev. Respir. Dis. 1981; 123: 185-189. (Pubitemid 11146393)
22. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery J-L, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Heart J. 2009; 30: 2493-2537.
23. Badesch DB, Champion HC, Gomez Sanchez MA, Hoeper MM, Loyd JE, Manes A, McGoon M, Naeije R, Olschewski H, Oudiz RJ, et al. Diagnosis and assessment of pulmonary arterial hypertension. J. Am. Coll. Cardiols. 2009; 54 (1 Suppl.): S55-66.
24. Leuchte HH, Baumgartner RA, Nounou ME, Vogeser M, Neurohr C, Trautnitz M, Behr J,. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am. J. Respir. Crit. Care Med. 2006; 173: 744-750.
25. Boutou AK, Pitsiou GG, Trigonis I, Papakosta D, Kontou PK, Chavouzis N, Nakou C, Argyropoulou P, Wasserman K, Stanopoulos I,. Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension. Respirology 2011; 16: 451-458.
26. Leuchte HH, Neurohr C, Baumgartner R, Holzapfel M, Giehrl W, Vogeser M, Behr J,. Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. Am. J. Respir. Crit. Care Med. 2004; 170: 360-365. (Pubitemid 39214607)
27. Kawut SM, O'Shea MK, Bartels MN, Wilt JS, Sonett JR, Arcasoy SM,. Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir. Med. 2005; 99: 1431-1439. (Pubitemid 41487501)
28. Dumitrescu D, Oudiz RJ, Karpouzas G, Hovanesyan A, Jayasinghe A, Hansen JE, Rosenkranz S, Wasserman K,. Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing. PLoS ONE 2010; 5: e14293.
29. Yasunobu Y, Oudiz RJ, Sun X-G, Hansen JE, Wasserman K,. End-tidal Pco2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest 2005; 127: 1637-1646. (Pubitemid 46218789)
30. Arena R, Lavie CJ, Milani RV, Myers J, Guazzi M,. Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review. J. Heart Lung Transplant. 2010; 29: 159-173.
31. Strange C, Highland KB,. Pulmonary hypertension in interstitial lung disease. Curr. Opin. Pulm. Med. 2005; 11: 452-455. (Pubitemid 41291091)
32. Groepenhoff H, Vonk-Noordegraaf A, Boonstra A, Spreeuwenberg MD, Postmus PE, BoGaard HJ,. Exercise testing to estimate survival in pulmonary hypertension. Med. Sci. Sports Exerc. 2008; 40: 1725-1732. 10.249/MSS. 0b013e31817c92c0.